AAAAAA
Results:
1-10
|
Results: 10
Authors:
Dowlati, A
Levitan, N
Gordon, NH
Hoppel, CL
Gosky, DM
Remick, SC
Ingalls, ST
Berger, SJ
Berger, NA
Citation: A. Dowlati et al., Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer, CANC CHEMOT, 47(2), 2001, pp. 141-148
Authors:
Dowlati, A
Crosby, L
Remick, SC
Makkar, V
Levitan, N
Citation: A. Dowlati et al., Paclitaxel added to the cisplatin/etoposide regimen in extensive-stage small cell lung cancer - the use of complete response rate as the primary endpoint in phase II trials, LUNG CANC, 32(2), 2001, pp. 155-162
Authors:
Levitan, N
Dowlati, A
Shina, D
Craffey, M
Mackay, W
DeVore, R
Jett, J
Remick, SC
Chang, A
Johnson, D
Citation: N. Levitan et al., Multi-institutional phase I/II trial of paclitaxel, cisplatin, and etoposide with concurrent radiation for limited-stage small-cell lung carcinoma, J CL ONCOL, 18(5), 2000, pp. 1102-1109
Authors:
Levitan, N
Dowlati, A
Citation: N. Levitan et A. Dowlati, Paclitaxel for limited-stage small-cell lung cancer - Reply, J CL ONCOL, 18(19), 2000, pp. 3454-3454
Authors:
Shepherd, FA
Dancey, J
Ramlau, R
Mattson, K
Gralla, R
O'Rourke, M
Levitan, N
Gressot, L
Vincent, M
Burkes, R
Coughlin, S
Kim, Y
Berille, J
Citation: Fa. Shepherd et al., Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy, J CL ONCOL, 18(10), 2000, pp. 2095-2103
Authors:
Chak, A
Canto, MI
Cooper, GS
Isenberg, G
Willis, J
Levitan, N
Clayman, J
Forastiere, A
Heath, E
Sivak, MV
Citation: A. Chak et al., Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients, CANCER, 88(8), 2000, pp. 1788-1795
Authors:
Levitan, N
Dowlati, A
Remick, SC
Tahsildar, HI
Sivinski, LD
Beyth, R
Rimm, AA
Citation: N. Levitan et al., Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy - Risk analysis using Medicare claims data, MEDICINE, 78(5), 1999, pp. 285-291
Authors:
Dowlati, A
Levitan, N
Remick, SC
Citation: A. Dowlati et al., Evaluation of interleukin-6 in bronchoalveolar lavage fluid and serum of patients with lung cancer, J LA CL MED, 134(4), 1999, pp. 405-409
Authors:
Levitan, N
Citation: N. Levitan, Rehabilitation of lung cancer patients, REHABILITATION OF THE PATIENT WITH RESPIRATORY DISEASE, 1999, pp. 605-614
Authors:
Levitan, N
Dowlati, A
Craffey, M
Tahsildar, H
MacKay, W
McKenney, J
Remick, SC
Citation: N. Levitan et al., A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial, LUNG CANC, 22(3), 1998, pp. 227-234
Risultati:
1-10
|